EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives

Antonio Olivas-Martinez iD, Fei Gao iD, Holly Janes

Statistics in Medicine · 2026-06 · 45 (13-14)

DOI: 10.1002/sim.70618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 26.05.2026. Verfasst von Antonio Olivas-Martinez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Research Design, Equivalence Trials as Topic, Randomized Controlled Trials as Topic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Active‐controlled trials with non‐inferiority objectives are often used when effective interventions are available, but new options may offer advantages or meet public health needs. In these trials, participants are randomized to an experimental intervention or an active control. The traditional non‐inferiority criterion requires that the new intervention preserve a substantial proportion of the active control effect. A key challenge is the absence of a placebo arm, which necessitates reliance on historical data to estimate the active control effect and assumptions about how well this effect applies to the target population. Another challenge arises when the active control is highly effective, as the new intervention may still be valuable even if it does not meet the traditional criterion. This has motivated alternative criteria based on sufficient efficacy relative to a hypothetical placebo. In this work, we propose a general framework for designing and evaluating non‐inferiority trials that integrates all existing analytical methods and accommodates both traditional and alternative success criteria. The framework enables the systematic comparison of methods in terms of type I error, power, and robustness to misspecification of the active control effect. We illustrate its applicability in the design of a future HIV prevention trial with a highly effective active control. In this application, our framework identifies methods that provide greater efficiency and robustness than commonly used approaches and demonstrates practical advantages of the alternative non‐inferiority criterion. Overall, this framework offers a comprehensive toolkit for rigorous non‐inferiority trial design, supporting method selection and the evaluation of new interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignEquivalence Trials as TopicRandomized Controlled Trials as TopicHumansHIV InfectionsAnti-HIV AgentsModels, Statistical

Stichwörter der Autor:innen

active‐controlled trialshistorical controlsinferred efficacynon‐inferioritypreservation of effectstudy design

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Bioinformatics and Epidemiology Program Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, Washington, USA.

ORCID-Profile: Antonio Olivas-Martinez, Fei Gao

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Olivas-Martinez, A., Gao, F., & Janes, H. (2026). A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70618

Vancouver

Olivas-Martinez A, Gao F, Janes H. A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70618

BibTeX
@article{OlivasMartinez2026,
  author = {Olivas-Martinez, Antonio and Gao, Fei and Janes, Holly},
  title = {A General Framework for Designing and Evaluating Active‐Controlled Trials with Non‐Inferiority Objectives},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {13-14},
  doi = {10.1002/sim.70618}
}
Kostenlos starten →